🇺🇸 FDA
Patent

US 10196458

Anti-immunoglobulin E antibodies and methods of using thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 10196458 (Anti-immunoglobulin E antibodies and methods of using thereof) held by The Regents of the University of California expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61P, A61P37/08